Content about Merck KGaA

June 7, 2013
Actavis seeks approval for two generics

Actavis is hoping to become the first to market generic versions of a contraceptive and a sedative, the drug maker said.

January 4, 2013
FDA approves new delivery method for MS drug

The Food and Drug Administration has approved a new means of administration for a multiple sclerosis drug, the manufacturers said.

October 11, 2012
Merck KGaA to donate $1.3 million per year to academic MS research

A German drug maker is pledging millions of dollars for multiple sclerosis research, the company's U.S. subsidiary said Thursday.

August 17, 2012
Generics offer affordability for specialty Rx

The U.S. healthcare system presents a paradox: It’s the most expensive system in the world, and yet it produces among the worst results among developed countries.

June 6, 2012
Dr. Reddy's, Merck KGaA partner on biosimilars

A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.

May 16, 2012
Amneal adds blackberry flavoring to generic diabetes drug

Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.

April 20, 2012
Genzyme to present MS drug trials

Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.

March 8, 2012
Prime Therapeutics, Merck KGaA subsidiary enter contractual agreement over MS drug

A pharmacy benefit manager and the U.S. subsidiary of a German drug maker have made a deal concerning a drug for multiple sclerosis.

December 21, 2011
Genzyme reports lackluster results in MS drug trial

An orally administered drug made by Genzyme for treating multiple sclerosis did not appear superior to a biotech drug already on the market, according to results of a late-stage clinical trial.

November 23, 2011
Report: Merck KGaA alleges that Merck took over its Facebook page

Facebook wars happen all the time, but it's not often that drug manufacturers duke it out online.

November 14, 2011
Genzyme announces phase-3 results of Lemtrada in patients with relapsing MS

A late-stage clinical trial of a drug under development as a treatment for multiple sclerosis has shown "successful" results.

October 7, 2011
Merck's Juvisync approved for Type 2 diabetes, high cholesterol

The Food and Drug Administration has approved a drug that it called the first single-pill combination treatment for Type 2 diabetes and high cholesterol.

October 6, 2011
Merck KGaA, Ono sign agreement for oral MS, cancer drugs

German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.

September 8, 2011
Robert Yates to lead Merck KGaA's life science division

Merck KGaA announced that Robert Yates was named president of Merck Millipore, the drug maker's life science division.

August 4, 2011
Merck KGaA completes enrollment in late-stage trial for Parkinson's disease drug

German drug maker Merck KGaA said it finished enrolling patients in a late-stage clinical study of a drug for Parkinson's disease.

July 7, 2011
Merck Serono names new COO

Merck KGaA division Merck Serono has appointed Belen Garijo as COO and Annalisa Jenkins as global head of drug development and medical, effective Sept. 5.

June 13, 2011
Merck, Hanwha to develop Enbrel biosimilar

Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.

March 3, 2011
Merck receives CRL for MS treatment

The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.

December 21, 2010
Dey Pharma settles DoJ suit

A Mylan subsidiary has settled a lawsuit brought on by the Department of Justice four years ago.

November 29, 2010
FDA review of MS drug extended, EMD Serono says

The Food and Drug Administration has extended its review period for a multiple sclerosis drug made by EMD Serono, the drug maker said Friday.

September 30, 2010
Study: Jevtana combined with Novantrone reduced death risk in prostate cancer patients

Data published in the latest issue of medical journal The Lancet showed that a recently...

July 15, 2010
Millipore officially becomes part of Merck KGaA

German drug maker Merck KGaA has finished acquiring U.S. life-sciences company Millipore, Merck KGaA said...

June 16, 2010
Clinical trial for Merck KGaA's cancer vaccine continues

A division of German drug maker Merck KGaA has resumed its clinical trial of a...

March 25, 2010
New clinical trial will compare MS drugs

Swiss drug maker Biogen Idec and Irish drug maker Elan Corp. have started enrolling patients...

March 22, 2010
Merck KGaA suspends cancer vaccine trial

A mid-stage clinical trial program to investigate a Merck KGaA cancer vaccine has been put...

© 2013 Drug Store News. All Rights Reserved.